scispace - formally typeset
R

Ruiliang Bai

Researcher at Zhejiang University

Publications -  54
Citations -  1111

Ruiliang Bai is an academic researcher from Zhejiang University. The author has contributed to research in topics: Medicine & Magnetic resonance imaging. The author has an hindex of 15, co-authored 31 publications receiving 700 citations. Previous affiliations of Ruiliang Bai include Sir Run Run Shaw Hospital & University of Maryland, College Park.

Papers
More filters
Journal ArticleDOI

Core-Satellite Polydopamine-Gadolinium-Metallofullerene Nanotheranostics for Multimodal Imaging Guided Combination Cancer Therapy.

TL;DR: The as‐prepared CDPGM NPs show good biocompatibility, strong NIR absorption, high relaxivity, low risk of release of Gd ions, and NIR‐triggered drug release, and suggest that the CDP GM NPs hold great promise for cancer theranostics.
Journal ArticleDOI

Dynamically Reversible Iron Oxide Nanoparticle Assemblies for Targeted Amplification of T1-Weighted Magnetic Resonance Imaging of Tumors.

TL;DR: P pH-sensitive iron oxide nanoparticle assemblies (IONAs) that are cross-linked by small-molecular aldehyde derivative ligands are reported, demonstrating a novel T1 magnetic resonance imaging (MRI) strategy for highly sensitive imaging of acidic tumors.
Journal ArticleDOI

Suppressing Nanoparticle-Mononuclear Phagocyte System Interactions of Two-Dimensional Gold Nanorings for Improved Tumor Accumulation and Photothermal Ablation of Tumors

TL;DR: In vitro and in vivo nanobio interactions of a two-dimensional (2D) model, gold (Au) nanorings, which were compared with Au nanospheres and Au nanoplates of similar size demonstrated the potential use of Au naonrings in photoacoustic imaging and photothermal therapy.
Journal ArticleDOI

T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents.

TL;DR: The paradigm of manipulating the multiparameter MRI, T1-T2 dual-modal MRI, along with enhancement by specific contrast agents are introduced, to provoke the rational design of contrast agents for sophisticated MRI applications.
Journal ArticleDOI

An Ultrahigh-Field-Tailored T 1 -T 2 Dual-Mode MRI Contrast Agent for High-Performance Vascular Imaging

TL;DR: By virtue of high‐resolution UHF MRI and a simple double‐checking process, UDIOC‐based dual‐mode dynamic contrast‐enhanced MRI is successfully applied to detect tumor vascular permeability with extremely high sensitivity and accuracy, providing a novel paradigm for the precise medical diagnosis of vascular‐related diseases.